Why the study?
Does severe preoperative hypertension increase perioperative cardiovascular complications or affect survival in adult kidney transplant recipients?
Does severe preoperative hypertension increase perioperative cardiovascular complications or affect survival in adult kidney transplant recipients?
Answers are grounded in this paper and cite their sources.
Severe preoperative hypertension does not appear to significantly increase perioperative cardiac events or negatively impact 1-year survival in clinically stable kidney transplant recipients.
BACKGROUND: Severe systemic hypertension (HTN) is a risk factor for perioperative cardiovascular complications; however, its impact at the time of kidney transplantation (KTX) is not well defined. METHODS: A retrospective cohort study of adult kidney-only transplant recipients between October 2009 and December 2012 was performed to examine outcomes between patients with (n = 111) and without (n = 98) severe preoperative HTN defined as SBP > 180 or DBP > 110 mmHg. RESULTS: Recipients with severe HTN were older (56.7 ± 13.0 vs. 53.5 ± 12.4 yr, p = 0.07) and significantly more likely to receive an expanded criteria donor kidney (32.7% vs. 12.2%, p = 0.02). No patients developed hypertensive crisis, intracranial hemorrhage, or life threatening ventricular arrhythmias within 30 d post-transplantation; however, three patients with severe HTN had cardiac events: two with demand ischemia and one with decompensate heart failure. Two patients in the control group had decompensated heart failure. There were no differences between the groups in terms of cardiac event (2.7% vs. 2.0%, p = 0.75), one-yr patient survival (98.2% vs. 98.0%, p = 0.90) or graft survival (90.1% vs. 92.9%, p = 0.48), nadir creatinine > 2 mg/dL (4.6% vs. 6.2%, p = 0.62), length of stay > 6 d (37.8% vs. 35.7%, p = 0.75), and DGF (52.3% vs. 63.3%, p = 0.11). CONCLUSIONS: Our results suggest that severe preoperative HTN should not be considered an absolute contraindication to kidney transplant in patients who are otherwise clinically stable.
No takes yet. Share an insight, caveat, or question.
Ajaimy et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: